BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8249123)

  • 1. Blood distribution of rapamycin.
    Yatscoff R; LeGatt D; Keenan R; Chackowsky P
    Transplantation; 1993 Nov; 56(5):1202-6. PubMed ID: 8249123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood distribution of mycophenolic acid.
    Langman LJ; LeGatt DF; Yatscoff RW
    Ther Drug Monit; 1994 Dec; 16(6):602-7. PubMed ID: 7878701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.
    Yatscoff RW; Wang P; Chan K; Hicks D; Zimmerman J
    Ther Drug Monit; 1995 Dec; 17(6):666-71. PubMed ID: 8588238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic monitoring of rapamycin: a new immunosuppressive drug.
    Yatscoff RW; LeGatt DF; Kneteman NM
    Ther Drug Monit; 1993 Dec; 15(6):478-82. PubMed ID: 8122280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rapamycin.
    Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):970-3. PubMed ID: 8623483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
    Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
    Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of rapamycin in whole blood by HPLC.
    Svensson JO; Brattström C; Säwe J
    Ther Drug Monit; 1997 Feb; 19(1):112-6. PubMed ID: 9029760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of rapamycin transport and uptake across absorptive human intestinal cell monolayers.
    Dias VC; Yatscoff RW
    Clin Biochem; 1994 Feb; 27(1):31-6. PubMed ID: 8200112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update.
    Trepanier DJ; Gallant H; Legatt DF; Yatscoff RW
    Clin Biochem; 1998 Jul; 31(5):345-51. PubMed ID: 9721433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection.
    Napoli KL; Kahan BD
    Clin Chem; 1996 Dec; 42(12):1943-8. PubMed ID: 8969630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations.
    Napoli KL; Kahan BD
    J Chromatogr B Biomed Appl; 1994 Mar; 654(1):111-20. PubMed ID: 8004232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.
    Yatscoff RW; Honcharik N; Lukowski M; Thliveris J; Chackowsky P; Faraci C
    Clin Chem; 1993 Feb; 39(2):213-7. PubMed ID: 8432008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioreceptor assay for sirolimus.
    Goodyear N; Napoli KL; Murthy JN; Kahan BD; Soldin SJ
    Clin Biochem; 1996 Oct; 29(5):457-60. PubMed ID: 8884067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography.
    Yatscoff RW; Faraci C; Bolingbroke P
    Ther Drug Monit; 1992 Apr; 14(2):138-41. PubMed ID: 1585399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioreceptor assay for sirolimus in patients with decreased platelet counts.
    Goodyear N; Napoli KL; Murthy JN; Kahan BD; Soldin SJ
    Clin Biochem; 1997 Oct; 30(7):539-43. PubMed ID: 9399022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in sirolimus stability in humans, rabbits, and rats.
    Ferron GM; Jusko WJ
    Drug Metab Dispos; 1998 Jan; 26(1):83-4. PubMed ID: 9443858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients.
    Hoogeveen RC; Ballantyne CM; Pownall HJ; Opekun AR; Hachey DL; Jaffe JS; Oppermann S; Kahan BD; Morrisett JD
    Transplantation; 2001 Oct; 72(7):1244-50. PubMed ID: 11602850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of cyclosporin A to human plasma: an in vitro microdialysis study.
    Yang H; Elmquist WF
    Pharm Res; 1996 Apr; 13(4):622-7. PubMed ID: 8710757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin.
    Kahan BD; Chang JY; Sehgal SN
    Transplantation; 1991 Aug; 52(2):185-91. PubMed ID: 1871787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.